Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aspinall

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Relationship between follicle-stimulating hormone levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: the FREEDOM studyF Miro, S W Parker, L J Aspinall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver DiseaseTheresa J Hydes, Paul Meredith, Paul E Schmidt, et al.
Frontline Gastroenterology|February 22, 2021
Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver diseaseAndrew J Fowell, Kirsty Fancey, Karen Gamble, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 7, 2017
Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015Esther J Aspinall, Elisabeth Couturier, Mirko Faber, et al.
Frontline Gastroenterology|March 15, 2024
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosisBenjamin Giles, Kirsty Fancey, Karen Gamble, et al.
Drug and Alcohol Dependence|December 16, 2014
Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012Dhanya Nambiar, Amanda Weir, Esther J Aspinall, et al.
The International Journal on Drug Policy|June 30, 2015
Global policy and access to new hepatitis C therapies for people who inject drugsJoseph S Doyle, Esther J Aspinall, Sharon J Hutchinson, et al.
HIV Medicine|March 1, 2018
Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016)E J Aspinall, S J Hutchinson, D J Goldberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levelsRichard J Aspinall, Sara M Weis, Leo Barnes, et al.
The International Journal on Drug Policy|December 10, 2013
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II studyE J Aspinall, A Weir, R Sacks-Davis, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Relationship between follicle-stimulating hormone levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: the FREEDOM studyF Miro, S W Parker, L J Aspinall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver DiseaseTheresa J Hydes, Paul Meredith, Paul E Schmidt, et al.
Frontline Gastroenterology|February 22, 2021
Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver diseaseAndrew J Fowell, Kirsty Fancey, Karen Gamble, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 7, 2017
Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015Esther J Aspinall, Elisabeth Couturier, Mirko Faber, et al.
Frontline Gastroenterology|March 15, 2024
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosisBenjamin Giles, Kirsty Fancey, Karen Gamble, et al.
Drug and Alcohol Dependence|December 16, 2014
Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012Dhanya Nambiar, Amanda Weir, Esther J Aspinall, et al.
The International Journal on Drug Policy|June 30, 2015
Global policy and access to new hepatitis C therapies for people who inject drugsJoseph S Doyle, Esther J Aspinall, Sharon J Hutchinson, et al.
HIV Medicine|March 1, 2018
Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016)E J Aspinall, S J Hutchinson, D J Goldberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levelsRichard J Aspinall, Sara M Weis, Leo Barnes, et al.
The International Journal on Drug Policy|December 10, 2013
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II studyE J Aspinall, A Weir, R Sacks-Davis, et al.
Pageof 13